A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Infection and Immunity

• Publication date

  1995-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/iai.63.9.3279-3286.1995PMID 7642256PMCID PMC173452
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preferential interaction of Salmonella typhimurium with mouse Peyer's patch M cells.

  1994cited by this paper
• Systemic and mucosal immune responses in mice orally immunized with avirulent Salmonella typhimurium expressing a cloned Porphyromonas gingivalis hemagglutinin

  1994cited by this paper
• Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi

  1994cited by this paper
• Hybrid hepatitis B virus core-pre-S proteins synthesized in avirulent Salmonella typhimurium and Salmonella typhi for oral vaccination

  1994cited by this paper
• Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer's patches

  1994cited by this paper
• Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces

  1994cited by this paper
• Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit

  1993cited by this paper
• Transepithelial transport and mucosal defence I: the role of M cells.

  1992cited by this paper
• Prospects for oral vaccination using recombinant bacteria expressing viral epitopes.

  1992cited by this paper
• The role of nasopharyngeal lymphoid tissue.

  1992cited by this paper
• Molecular and cellular basis of immune protection of mucosal surfaces.

  1992cited by this paper
• Hepatitis B virus nucleocapsid/pre-S2 fusion proteins expressed in attenuated Salmonella for oral vaccination.

  1990cited by this paper
• Antigen recognition in the female reproductive tract: I. Uptake of intraluminal protein tracers in the mouse vagina.

  1990influential reference
• Constitutive expression of the phoP regulon attenuates Salmonella virulence and survival within macrophages

  1990cited by this paper
• Recognition of a hepatitis B virus nucleocapsid T-cell epitope expressed as a fusion protein with the subunit B of Escherichia coli heat labile enterotoxin in attenuated salmonellae.

  1990cited by this paper
• Specific immune response in humans following rectal delivery of live typhoid vaccine.

  1990cited by this paper
• Immunology and Immunopathology of the Intestines: Recombinant Avirulent Salmonella Vaccine Strains with Stable Maintenance and High Level Expression of Cloned Genes in Vivo

  1989cited by this paper
• Structure and function of bronchus-associated lymphoid tissue (BALT).

  1989cited by this paper
• Immune response to hepatitis B virus core antigen (HBcAg): localization of T cell recognition sites within HBcAg/HBeAg.

  1987cited by this paper
• The common mucosal immune system and current strategies for induction of immune responses in external secretions

  1987cited by this paper
• The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen.

  1986cited by this paper
• The effect of atrophy, hyperplasia, and keratinization accompanying the estrous cycle on Langerhans' cells in mouse vaginal epithelium.

  1985cited by this paper
• Comparison of Enzyme-Linked Immunosorbent Assay and Passive Hemagglutination Method for Quantification of Antibodies to Lipopolysaccharide and Tetanus Toxoid in Rats

  1979cited by this paper
• Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues.

  1979cited by this paper
• Immunogenicity, tolerogenicity, and mitogenicity of lipopolysaccharides.

  1973cited by this paper
• Local antibody response to poliovaccine in the human female genital tract.

  1973cited by this paper

• The Papain-like Protease Domain of Severe Acute Respiratory Syndrome Coronavirus 2 Conjugated with Human Beta-Defensin 2 and Co1 Induces Mucosal and Systemic Immune Responses against the Virus

  2024cites this paper
• mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine

  2023cites this paper
• Oral non-viral gene delivery platforms for therapeutic applications.

  2023cites this paper
• Bacteria-enabled oral delivery of a replicon-based mRNA vaccine candidate protects against ancestral and delta variant SARS-CoV-2

  2022cites this paper
• A Simplified SARS-CoV-2 Mouse Model Demonstrates Protection by an Oral Replicon-Based mRNA Vaccine

  2022cites this paper
• Oral mRNA Vaccines Against Infectious Diseases- A Bacterial Perspective [Invited]

  2022cites this paper
• Protective immunity enhanced Salmonella vaccine vectors delivering Helicobacter pylori antigens reduce H. pylori stomach colonization in mice

  2022cites this paper
• Eradication of Intracellular Salmonella Typhimurium by Polyplexes of Acid-Transforming Chitosan and Fragment DNA.

  2021cites this paper
• Enhanced SARS-CoV-2 neutralization by dimeric IgA

  2020cites this paper
• Alternative vaccine delivery methods

  2020cites this paper
• Differentially regulated promoters for antigen expression in Salmonella vaccine strains.

  2020cites this paper
• Bacterial Endotoxins and Their Role in Periparturient Diseases of Dairy Cows: Mucosal Vaccine Perspectives

  2020cites this paper
• Mucosal Vaccination Challenges in Aging: Understanding Immunosenescence in the Aerodigestive Tract

  2019cites this paper
• Mucosal associated invariant T cell-mediated vaccination and protection against pathogenic bacteria

  2018cites this paper
• Evaluation of the Effect of Promoter Type on the Immunogenicity of the Live Recombinant Salmonella Vaccines Expressing Escherichia Coli Heat-labile Enterotoxins (LTB)

  2018cites this paper
• Oral immunization with a novel attenuated Salmonella Typhimurium encoding influenza HA, M2e and NA antigens protects chickens against H7N9 infection

  2018cites this paper
• Polyester Particles for Drug Delivery to the Skin: Local and Systemic Applications

  2017cites this paper
• Salmonella Typhimurium, the major causative agent of foodborne illness inactivated by a phage lysis system provides effective protection against lethal challenge by induction of robust cell-mediated immune responses and activation of dendritic cells

  2017cites this paper
• Influenza H7N9 LAH-HBc virus-like particle vaccine with adjuvant protects mice against homologous and heterologous influenza viruses.

  2016cites this paper
• Mucosal vaccine delivery: Current state and a pediatric perspective.

  2016cites this paper
• Antigen Delivery System II

  2015cites this paper
• Intravaginal live attenuated Salmonella increase local antitumor vaccine-specific CD8+ T cells

  2013cites this paper
• The Asd+-DadB+ Dual-Plasmid System Offers a Novel Means To Deliver Multiple Protective Antigens by a Recombinant Attenuated Salmonella Vaccine

  2012cites this paper
• Rectal single dose immunization of mice with Escherichia coli O157:H7 bacterial ghosts induces efficient humoral and cellular immune responses and protects against the lethal heterologous challenge

  2012cites this paper
• A Pilot Study on Developing Mucosal Vaccine against Alveolar Echinococcosis (AE) Using Recombinant Tetraspanin 3: Vaccine Efficacy and Immunology

  2012cites this paper
• Mucosal Adjuvanticity of Fibronectin-Binding Peptide (FBP) Fused with Echinococcus multilocularis Tetraspanin 3: Systemic and Local Antibody Responses

  2012cites this paper
• Attenuated Salmonella typhimurium delivering DNA vaccine encoding duck enteritis virus UL24 induced systemic and mucosal immune responses and conferred good protection against challenge

  2012cites this paper
• Abordagem sobre Salmonella sp. com enfoque na caracterização, patogênese e métodos de diagnóstico em aves

  2011cites this paper
• A Murine Genital-Challenge Model Is a Sensitive Measure of Protective Antibodies against Human Papillomavirus Infection

  2011cites this paper
• Therapeutic efficacy of oral immunization with attenuated Salmonella typhimurium expressing Helicobacter pylori CagA, VacA and UreB fusion proteins in mice model.

  2011cites this paper
• Live Attenuated Salmonella Vaccines Displaying Regulated Delayed Lysis and Delayed Antigen Synthesis To Confer Protection against Mycobacterium tuberculosis

  2011cites this paper
• Progress Towards a Needle-Free Hepatitis B Vaccine

  2011cites this paper
• Construction and characterization of recombinant attenuated Salmonella typhimurium expressing the babA2/ureI fusion gene of Helicobacter pylori.

  2011cites this paper
• Live Vaccine Carriers

  2010cites this paper
• NALT (nasal cavity-associated lymphoid tissue) in the rabbit.

  2010cites this paper
• Salmonella Vaccine Vectors Displaying Delayed Antigen Synthesis InVivo To Enhance Immunogenicity

  2010cites this paper
• Evaluation of the humoral immune response in mice orally vaccinated with live recombinant attenuated Salmonella enterica delivering a secreted form of Yersinia pestis PsaA.

  2010cites this paper
• Immunisation of the equine uterus against Streptococcus equi subspecies zooepidemicus using an intranasal attenuated Salmonella vector.

  2010cites this paper
• Helicobacter pylori vaccine: mucosal adjuvant & delivery systems.

  2009cites this paper
• Rectal and vaginal immunization of mice with human papillomavirus L1 virus-like particles.

  2009cites this paper
• TATIANA RODRIGUES FRAGA ESTUDO DE POTENCIAIS ANTÍGENOS VACINAIS DE LEPTOSPIRA INTERROGANS

  2009cites this paper
• Use of genetically modified bacteria to modulate adaptive immunity.

  2009cites this paper
• Human IgA‐secreting cells induced by intestinal, but not systemic, immunization respond to CCL25 (TECK) and CCL28 (MEC)

  2008cites this paper
• Presence of Wild-Type and Attenuated Salmonella enterica Strains in Brain Tissues following Inoculation of Mice by Different Routes

  2008cites this paper
• Salmonella enterica Serovar Typhimurium Strains with Regulated Delayed Attenuation In Vivo

  2008cites this paper
• Analysis of Type II Secretion of Recombinant Pneumococcal PspA and PspC in a Salmonella enterica Serovar Typhimurium Vaccine with Regulated Delayed Antigen Synthesis

  2008cites this paper
• Intravaginal Immunization of Mice with Recombinant Salmonella enterica Serovar Typhimurium Expressing Human Papillomavirus Type 16 Antigens as a Potential Route of Vaccination against Cervical Cancer

  2008influential citation
• Subcutaneous Vaccination with Attenuated Salmonella enterica Serovar Choleraesuis C500 Expressing Recombinant Filamentous Hemagglutinin and Pertactin Antigens Protects Mice against Fatal Infections with both S. enterica Serovar Choleraesuis and Bordetella bronchiseptica

  2008cites this paper
• Salmonella enterica Serovar Typhi Ty21a Expressing Human Papillomavirus Type 16 L1 as a Potential Live Vaccine against Cervical Cancer and Typhoid Fever

  2007cites this paper
• Salmonella infections: immune and non-immune protection with vaccines

  2007cites this paper
• Humoral and cellular immune responses to airway immunization of mice with human papillomavirus type 16 virus-like particles and mucosal adjuvants.

  2007cites this paper
• A comparison of immunogenicity and protective immunity against experimental plague by intranasal and/or combined with oral immunization of mice with attenuated Salmonella serovar Typhimurium expressing secreted Yersinia pestis F1 and V antigen

  2007cites this paper
• Utilising salmonella to deliver heterologous vaccine antigen

  2007cites this paper
• Immunogenicity of Salmonella vector vaccines expressing SBR of Streptococcus mutans under the control of a T7-nirB (dual) promoter system.

  2006cites this paper
• Rational design of Salmonella-based vaccination strategies.

  2006cites this paper
• Host cell responses of Salmonella typhimurium infected human dendritic cells

  2006cites this paper
• Intranasal Vaccination with Recombinant Adeno-Associated Virus Type 5 against Human Papillomavirus Type 16 L1

  2006cites this paper
• Intrarectal Immunization with Rotavirus 2/6 Virus-Like Particles Induces an Antirotavirus Immune Response Localized in the Intestinal Mucosa and Protects against Rotavirus Infection in Mice

  2006cites this paper
• Chapter 7 – Cellular and Molecular Basis for Antigen Transport Across Epithelial Barriers

  2005cites this paper
• Kinetics of Local and Systemic Immune Responses after Vaginal Immunization with Recombinant Cholera Toxin B Subunit in Humans

  2005cites this paper
• Immune responses induced by lower airway mucosal immunisation with a human papillomavirus type 16 virus-like particle vaccine.

  2005cites this paper
• Microparticles for oral delivery of vaccines

  2005cites this paper
• Mucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties

  2005cites this paper
• Striking phenotypic and functional differences in lamina propria lymphocytes from the large and small intestine of mice.

  2005cites this paper
• Vaccination and early protection against non-host-specific Salmonella serotypes in poultry: exploitation of innate immunity and microbial activity

  2005cites this paper
• Virulence Attenuation and Live Vaccine Potential of aroA, crp cdt cya, and Plasmid-Cured Mutants of Salmonella enterica Serovar Abortusovis in Mice and Sheep

  2005cites this paper
• Chapter 56 – Antigen Delivery Systems II: Development of Live Recombinant Attenuated Bacterial Antigen and DNA Vaccine Delivery Vector Vaccines

  2005cites this paper
• Chapter 32 – The Human Mucosal B-Cell System

  2005cites this paper
• Protective efficacy of IgA monoclonal antibodies to O and H antigens in a mouse model of intranasal challenge with Salmonella enterica serotype Enteritidis.

  2004cites this paper
• Immunogenicity against Human Papillomavirus Type 16 Virus-Like Particles Is Strongly Enhanced by the PhoPc Phenotype in Salmonella enterica Serovar Typhimurium

  2004cites this paper
• Efficacy of genital T cell responses to herpes simplex virus type 2 resulting from immunization of the nasal mucosa.

  2004cites this paper
• Salmonella como vetor de vacinas vivas orais

  2004cites this paper
• Antibody response in mice immunized by mucosal routes with formalin-inactivated enteropathogenic Escherichia coli (EPEC) strains.

  2004cites this paper
• Mucosal immunity

  2004cites this paper
• Improved Efficiency of a Salmonella-Based Vaccine against Human Papillomavirus Type 16 Virus-Like Particles Achieved by Using a Codon-Optimized Version of L1

  2004cites this paper
• Mucosal immunogenicity of the hepatitis B core antigen.

  2003cites this paper
• CELLULAR IMMUNITY AND CHLAMYDIA GENITAL INFECTION: INDUCTION, RECRUITMENT, AND EFFECTOR MECHANISMS

  2003cites this paper
• Human Alveolar Macrophages Infected by Virulent Bacteria Expressing SipB Are a Major Source of Active Interleukin-18

  2003cites this paper
• Mutational Analysis of the Residue at Position 48 in the Salmonella enterica Serovar Typhimurium PhoQ Sensor Kinase

  2003cites this paper
• Construction and identification of a recombinant live attenuated Salmonella typhimurium vaccine strain carrying Helicobacter pylori heat shock protein subunit B gene

  2003cites this paper
• Reducing colonization of Salmonella Enteritidis in chicken by targeting outer membrane proteins

  2003cites this paper
• The role of mucosal immunity in prevention of HIV transmission.

  2003cites this paper
• CHAPTER 15 – Characteristics of Mucosal B Cells with Emphasis on the Human Secretory Immune System

  2003cites this paper
• IMMUNIZATION VIA THE COLONIC MUCOSA USING ADENOVIRAL VECTORS

  2003cites this paper
• Animal models paving the way for clinical trials of attenuated Salmonella enterica serovar Typhi live oral vaccines and live vectors.

  2003cites this paper
• Immunization with Attenuated Salmonella typhimurium Producing Catalase in Protection against Gastric Helicobacter pylori Infection in Mice

  2003cites this paper
• Differential Induction of Mucosal and Systemic Antibody Responses in Women After Nasal, Rectal, or Vaginal Immunization: Influence of the Menstrual Cycle1

  2002cites this paper
• Bordetella bronchiseptica: A Candidate Mucosal Vaccine Vector

  2002cites this paper
• Trachea, Lung, and Tracheobronchial Lymph Nodes Are the Major Sites Where Antigen-Presenting Cells Are Detected after Nasal Vaccination of Mice with Human Papillomavirus Type 16 Virus-Like Particles

  2002cites this paper
• Nasal Immunization with Homogenate and Peptide Antigens Induces Protective Immunity against Trichinella spiralis

  2002cites this paper
• The ahp promoter of Salmonella enterica sv. typhimurium : regulation and merits for heterologous antigen expression in vivo

  2002cites this paper
• Construction of an attenuated Salmonella typhimurium vaccine carrying the Helicobacter pylori hpaA gene

  2002cites this paper
• Slight influence of the estrous cycle stage on the mucosal and systemic specific antibody response induced after vaginal and intraperitoneal immunization with protoxin Cry1Ac from Bacillus thuringiensis in mice.

  2002cites this paper
• The immune response in mice challenged with bacterial infections

  2002cites this paper
• Intranasal immunization with recombinant antigens associated with new cationic particles induces strong mucosal as well as systemic antibody and CTL responses.

  2002cites this paper
• CycleImmunization: Influence of the Menstrual After Nasal, Rectal, or Vaginal Systemic Antibody Responses in Women Differential Induction of Mucosal and

  2002cites this paper
• Lipopolysaccharide-Specific but Not Anti-Flagellar Immunoglobulin A Monoclonal Antibodies Prevent Salmonella enterica Serotype Enteritidis Invasion and Replication within HEp-2 Cell Monolayers

  2002cites this paper
• Rational attenuation of Bordetella bronchiseptica for vaccine purposes

  2002cites this paper
• Regional Immune Response to Microbial Pathogens

  2002cites this paper
• Nasal immunisation with Salmonella typhimurium producing rotavirus VP2 and VP6 antigens stimulates specific antibody response in serum and milk but fails to protect offspring.

  2001cites this paper